| Literature DB >> 30409906 |
Woosuk S Hur1,2, Nima Mazinani1,2, X J David Lu1,2, Leeor S Yefet1, James R Byrnes3, Laura Ho1, Ju Hun Yeon1, Sam Filipenko1, Alisa S Wolberg3, Wilfred A Jefferies1,4, Christian J Kastrup5,2.
Abstract
In cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD), the amyloid β (Aβ) peptide deposits along the vascular lumen, leading to degeneration and dysfunction of surrounding tissues. Activated coagulation factor XIIIa (FXIIIa) covalently cross-links proteins in blood and vasculature, such as in blood clots and on the extracellular matrix. Although FXIIIa co-localizes with Aβ in CAA, the ability of FXIIIa to cross-link Aβ has not been demonstrated. Using Western blotting, kinetic assays, and microfluidic analyses, we show that FXIIIa covalently cross-links Aβ40 into dimers and oligomers (k cat/Km = 1.5 × 105 m-1s-1), as well as to fibrin, platelet proteins, and blood clots under flow in vitro Aβ40 also increased the stiffness of platelet-rich plasma clots in the presence of FXIIIa. These results suggest that FXIIIa-mediated cross-linking may contribute to the formation of Aβ deposits in CAA and Alzheimer's disease.Entities:
Keywords: Alzheimer's disease; amyloid-beta (AB); coagulation factor XIII; fibrin; neurodegeneration; oligomerization; protein aggregation; transglutaminase; vascular biology
Mesh:
Substances:
Year: 2018 PMID: 30409906 PMCID: PMC6333891 DOI: 10.1074/jbc.RA118.005352
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157